Lonza is at long last shedding its capsules and health ingredients (CHI) business in a private equity sale that could see proceeds of 3 billion Swiss francs ($4 billion) or more. | Under the deal ...
Labeling issues are at the root of four nationwide recalls affecting more than 35 million fenofibrate capsules from Impax Laboratories and a unit of AmerisourceBergen ...
SANTA ANA, Calif, Dec. 18, 2025 /PRNewswire/ -- Robinson Pharma Inc., a leading USA-based contract manufacturer of dietary supplements, today announced a significant expansion of its manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results